83504-151 : Exxua 36.3 mg Oral Tablet, Delayed Release
NDC: | 83504-151 |
Labeler: | Fabre Kramer Pharmaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Exxua |
Dosage Form: | Oral Tablet, Delayed Release |
Application #: | NDA021164 |
Rev. Date: |
NDC Package Codes:
- 83504-151-10: 100 TABLET, DELAYED RELEASE IN 1 BOTTLE (83504‑151‑10)
Active Ingredients:
- Gepirone Hydrochloride
Dosage Strength:
- 36.3 mg
Related Products:
Based on records with the same trade name.- 83504-150 Exxua 18.2 mg Oral Tablet, Delayed Release by Fabre Kramer Pharmaceuticals, Inc.
- 83504-152 Exxua 54.5 mg Oral Tablet, Delayed Release by Fabre Kramer Pharmaceuticals, Inc.
- 83504-153 Exxua 72.6 mg Oral Tablet, Delayed Release by Fabre Kramer Pharmaceuticals, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 83504-150Next: 83504-152 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.